Clinical Trials Sponsored by Cancer Research Network

Total 11089 results

Blokhin's Russian Cancer Research Center

Enrolling by invitation

Efficacy Study of Chemoradiotherapy With or Without Paclitaxel in Squamous-cell Anal Carcinoma Patients

Neoplasms | Carcinoma | Carcinoma, Squamous Cell | Neoplasms, Squamous Cell | Anus Neoplasms | Anus Diseases
Dana-Farber Cancer Institute
Novartis; National Comprehensive Cancer Network

Terminated

GSK1120212+GSK2141795 for Cervical Cancer

Cervical Cancer

United States
Ohio State University
Autism Treatment Network; Autism Intervention Research Network on Physical...

Withdrawn

Clonidine for Sleep Disturbances in Children With Autism Spectrum Disorder

Autism Spectrum Disorder

United States
Pancreatic Cancer Action Network
National Institutes of Health (NIH); Fred Hutchinson Cancer Center

Enrolling by invitation

Early Detection Initiative for Pancreatic Cancer (EDI)

Hyperglycemia | Diabetes Mellitus | Pancreas Ductal Adenocarcinoma

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...
Novartis; National Comprehensive Cancer Network

Completed

Phase 1 Study of Pazopanib With GSK1120212 in Advanced Solid Tumors, Enriched With Patients With Differentiated Thyroid Cancer, Soft-tissue Sarcoma, and Cholangiocarcinoma

Cholangiocarcinoma | Soft-tissue Sarcoma | Solid Tumors | Thyroid Cancer

United States
Blokhin's Russian Cancer Research Center

Not yet recruiting

A Prospective Clinical Study on the Safety and Efficacy of Radiofrequency Ablation for the Treatment of Patients With Desmoid Tumors (RFAdesmoid)

Desmoid Fibromatosis | Desmoid Tumor | Desmoid

Russian Federation
Blokhin's Russian Cancer Research Center

Recruiting

Prophylactic Mesh Placement During Stoma Closure After Low Anterior Resection (ProMeLAR)

Rectal Cancer | Surgery | Neoplasms Malignant | Hernia Incisional

Russian Federation
Blokhin's Russian Cancer Research Center

Recruiting

Neoadjuvant Endocrine Therapy in Breast Cancer. Real Clinical Practice in Russia (NEMO)

Breast Cancer | Neoadjuvant Endocrine Therapy

Russian Federation
Blokhin's Russian Cancer Research Center

Recruiting

Neoadjuvant Combination of Doxorubicin, Cisplatin and Methotrexate in Patients Aged 24-40 Years With Primary Bone Tumors

Sarcoma | Neoplasms, Connective and Soft Tissue | Osteosarcoma | Neoplasms, Connective Tissue | Sarcoma of Bone

Russian Federation
Blokhin's Russian Cancer Research Center

Recruiting

Wide Excision of Soft Tissue Sarcomas in Combination With Interstitial Radiation Therapy

Sarcoma | Soft Tissue Sarcoma

Russian Federation
Blokhin's Russian Cancer Research Center

Recruiting

Analysis of Therapy Sequence in Women With HR+, HER2 - mBC in Moscow: A Multicenter Retrospective Observational Study.

Breast Cancer Stage IV

Russian Federation
Blokhin's Russian Cancer Research Center

Enrolling by invitation

Induction and Consolidation Chemotherapy in Patients With Locally Advanced CRM-positive Rectal Cancer (RuCorT-03)

Rectal Cancer | Rectum Carcinoma | Rectal Neoplasms Malignant

Russian Federation
Blokhin's Russian Cancer Research Center

Enrolling by invitation

Neoadjuvant Chemotherapy in Patients With Moderate Risk Mid Rectal Cancer (RuCorT-02)

Rectal Cancer | Rectum Carcinoma | Rectal Neoplasms Malignant

Russian Federation
Blokhin's Russian Cancer Research Center

Unknown

Efficacy of Platinum-based Chemotherapy in Platinum-resistant Ovarian Cancer) (EPITOC) (EPITOC)

Ovarian Neoplasms | Ovarian Cancer | Chemotherapy | BRCA1 Mutation | BRCA2 Mutation | Serous Adenocarcinoma

Russian Federation
Iran Hepatitis Network
Baqiyatallah Research Center for Gastroenterology and Liver Diseases

Unknown

Treatment of Hepatitis C Virus Infection With Generic Sofosbuvir/Ledipasvir in Iranian Patients (HepCC-2)

Hepatitis C
Sanjay Mohan
National Comprehensive Cancer Network; Taiho Oncology, Inc.

Recruiting

Decitabine and Cedazuridine in Combination With Venetoclax for the Treatment of Patients Who Have Relapsed Acute Myeloid Leukemia After Donor Stem Cell Transplant

Recurrent Acute Myeloid Leukemia

United States
City of Hope Medical Center
National Cancer Institute (NCI); National Comprehensive Cancer Network

Completed

Intraperitoneal Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Cancer of the Peritoneal Cavity

Ovarian Cancer | Peritoneal Cavity Cancer | Unspecified Adult Solid Tumor, Protocol Specific

United States
Memorial Sloan Kettering Cancer Center
Eli Lilly and Company; National Comprehensive Cancer Network

Completed

Cetuximab at Either 500 or 750 mg/m2 Every Other Week for Recurrent or Metastatic Head and Neck Squamous Cell Cancer

Squamous Cell Cancer | Head and Neck

United States
Ohio State University Comprehensive Cancer Center
National Comprehensive Cancer Network; Spectrum Pharmaceuticals, Inc

Completed

Pralatrexate and Docetaxel in Treating Patients With Stage IV Esophageal or Gastroesophageal Cancer Who Have Failed Platinum-Based Therapy

Squamous Cell Carcinoma of the Esophagus | Adenocarcinomas of the Gastroesophageal Junction | Adenocarcinoma of the Esophagus | Recurrent Esophageal Cancer | Stage IV Esophageal Cancer

United States
Bryan Schneider, MD
Hoosier Cancer Research Network; Walther Cancer Institute; Vera Bradley Foundation... and other collaborators

Completed

Randomized Controlled Trial of Genomically Directed Therapy in Patients With Triple Negative Breast Cancer

Breast Cancer | Malignant Neoplasm of Breast

United States
Louisiana Public Health Institute
Patient-Centered Outcomes Research Institute; Centers for Disease Control and... and other collaborators

Completed

PCORnet Opioid Surveillance Study

Opioid Use | Opioid Abuse

United States
University of Washington
Bladder Cancer Advocacy Network

Recruiting

A Home-Based Prehabilitation Exercise Intervention for Improving Physical Function in Patients Receiving Chemotherapy Before Radical Cystectomy, Get Moving Trial

Stage IIIA Bladder Cancer AJCC v8 | Muscle Invasive Bladder Carcinoma | Stage II Bladder Cancer AJCC v8

United States
Essentia Health
Minnesota Cancer Clinical Trials Network

Recruiting

Safety of Extending The Routine Flushing Of Implanted Port Devices From 4 Weeks To 12

Maintenance of Implanted Port Devices

United States
Johns Hopkins University
National Comprehensive Cancer Network

Recruiting

The Delayed Intervention and Surveillance for Small Renal Masses (DISSRM) Registry (DISSRM)

Kidney Neoplasm

United States
Massachusetts General Hospital
National Comprehensive Cancer Network

Active, not recruiting

Tivozanib + Enzalutamide in Adv Prostate Cancer

Prostate Cancer

United States
Massachusetts General Hospital
National Comprehensive Cancer Network

Completed

Perioperative Geriatrics Intervention for Older Cancer Patients Undergoing Surgical Resection

Gastric Cancer | Pancreatic Cancer | Esophageal Cancer | Rectal Cancer | Colon Cancer | Hepatobiliary Cancer

United States
University Health Network, Toronto
Cancer Care Ontario

Terminated

Self-Management and Activation to Reduce Treatment-Related Toxicities (SMARTCare)

Lymphoma | Lung Cancer | Colo-rectal Cancer

Canada
Massachusetts General Hospital
National Comprehensive Cancer Network

Unknown

Adjuvant Afatinib in Stage I-III NSCLC With EGFR Mutation

Non Small Cell Lung Cancer

United States
Massachusetts General Hospital
National Comprehensive Cancer Network

Completed

Tivozanib for Recurrent Glioblastoma

Glioblastoma

United States
University Health Network, Toronto
Prostate Cancer Canada

Completed

18F-FCH (Fluorocholine)-PET/MR in Staging of High-Risk Prostate Cancer

Prostate Cancer

Canada
University of Utah
National Comprehensive Cancer Network

Completed

Sunitinib for Metastatic Renal Cell Cancer With Imaging Biomarker Assessments for the Early Prediction of Tumor Response

Renal Cell Cancer

United States
University Health Network, Toronto
Bladder Cancer Canada

Recruiting

Neoadjuvant Upper Tract Invasive Cancer Trial (NAUTICAL) (NAUTICAL)

Bladder Cancer | Bladder Urothelial Carcinoma

Canada
Massachusetts General Hospital
National Comprehensive Cancer Network

Active, not recruiting

Supportive Care Mobile Application for Patients With NSCLC

Quality of Life | Non Small Cell Lung Cancer | Coping Skills

United States
University Health Network, Toronto
Pancreatic Cancer Canada

Active, not recruiting

GATA6 Expression as a Predictor of Response to Peri-Operative Chemotherapy in Resectable Pancreatic Adenocarcinoma (NeoPancOne)

Resectable Pancreatic Cancer

Canada
University Health Network, Toronto
Prostate Cancer Canada

Completed

Toward a Comprehensive Supportive Care Intervention for Older or Frail Men With mCRPC (TOPCOP2)

Metastatic Prostate Cancer

Canada
University Health Network, Toronto
Prostate Cancer Canada

Completed

Towards Optimal Prescription of Chemotherapy in Prostate Cancer (TOPCOP)

Prostate Cancer

Canada
Northwestern University
GlaxoSmithKline; National Comprehensive Cancer Network

Active, not recruiting

Alemtuzumab-Ofatumumab in Previously Untreated Symptomatic Chronic Lymphocytic Leukemia

Stage I Chronic Lymphocytic Leukemia | Stage II Chronic Lymphocytic Leukemia | Stage III Chronic Lymphocytic Leukemia | Stage IV Chronic Lymphocytic Leukemia

United States, Sweden
Massachusetts General Hospital
National Comprehensive Cancer Network

Completed

Palliative And Oncology Care Model In Breast Cancer

Metastatic Breast Cancer

United States
University Health Network, Toronto
Cancer Care Ontario

Unknown

Evaluation of a 'Hand-held' Fluorescence Digital Imaging Device for Real-Time Advanced Wound Care Monitoring (JDRTC/UHN) (JDRTC/UHN)

Diabetic Foot Ulcers | Wounds

Canada
Massachusetts General Hospital
National Comprehensive Cancer Network

Completed

Carfilzomib Plus Belinostat in Relapsed/Refractory NHL

Follicular Lymphoma | Mantle Cell Lymphoma | Non-Hodgkin Lymphoma | Peripheral T-cell Lymphoma | Diffuse Large B-cell Lymphoma

United States
University Health Network, Toronto
Cancer Care Ontario

Completed

Evaluation of a 'Hand-Held' Fluorescence Digital Imaging Device for Real-Time Advanced Wound Care Monitoring (SMH/UHN) (SMH/UHN)

Surgical Wounds

Canada
Eastern Network of Cancer Immunological Therapy...

Terminated

Phase II Study of TS-1 Therapy and TS-1+PSK Therapy Against Advanced Gastric Carcinoma (eNCIT-Japan)

Gastric Cancer

Japan
Ryan Gentzler, MD
Mirati Therapeutics Inc.; University of Virginia

Recruiting

Adagrasib + SRS for Patients With Metastatic KRAS G12C-mutated NSCLC With Untreated Brain Metastases

NSCLC | Non Small Cell Lung Cancer | KRAS G12C

United States
Mylin A. Torres, MD
Pfizer; Genentech, Inc.; Emory University

Terminated

A Study to Evaluate TAlazoparib, Radiotherapy and Atezolizumab in gBRCA 1/2 Negative Patients With PD-L1+ Metastatic Triple Negative Breast Cancer (TARA)

Breast Cancer | Triple Negative Breast Cancer

United States
Greg Durm, MD
AstraZeneca; Indiana University School of Medicine

Terminated

Chemoradiation Plus Durvalumab Followed by Surgery Followed by Adjuvant Durvalumab in Patients With Surgically Resectable Stage III (N2) Non-Small Cell Lung Cancer

Non Small Cell Lung Cancer | Stage III Non-small-cell Lung Cancer

United States
University Health Network, Toronto
Princess Margaret Hospital, Canada; Ontario Institute for Cancer Research

Completed

Feasibility Study of Genomic Profiling Methods and Timing in Tumor Samples

Breast Cancer | Colorectal Cancer | Metastatic | Gynecological Cancer | Melanoma Cancer | Eligible for Phase I or Phase II Study

Canada
Rana McKay, MD
University of California, San Diego; AstraZeneca

Recruiting

Study of Neoadjuvant PARP Inhibition Followed by Radical Prostatectomy in Patients With Unfavorable Intermediate-Risk or High-Risk Prostate Cancer With BRCA1/2 Gene Alterations (NePtune)

Prostate Cancer | BRCA1 Mutation | BRCA2 Mutation | Prostatic Adenocarcinoma | High-Risk Cancer

United States
Colette Shen
AstraZeneca; University of North Carolina, Chapel Hill

Recruiting

Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physician's Choice Systemic Therapy in Subjects With Breast Cancer Brain Metastases (SOLARA)

Breast Cancer | Brain Metastases, Adult

United States
Harry H Yoon
Mayo Clinic; Merck Sharp & Dohme LLC

Recruiting

Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma (SEQUEL)

Adenocarcinoma | Gastric Cancer | GastroEsophageal Cancer

United States
Nabil Adra
Genentech, Inc.; Indiana University School of Medicine

Terminated

Trial of Atezolizumab Plus Chemotherapy After Progression on PD-1 or PD-L1 in Cisplatin-ineligible Patients With Advanced Urothelial Carcinoma

Urothelial Carcinoma

United States

Clinical Trials Sponsored by Cancer Research Network

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Angola

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations